Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data-Reference-Cited by-全球学者库

Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

Published:2017 Issue:2 Volume:17 Page:132
ISSN:2093-582X
Container-title:Journal of Gastric Cancer
language:en
Short-container-title:J Gastric Cancer

Author:

Fuchs Charles S.¹,Muro Kei²,Tomasek Jiri³,Van Cutsem Eric⁴,Cho Jae Yong⁵,Oh Sang-Cheul⁶,Safran Howard⁷,Bodoky György⁸,Chau Ian⁹,Shimada Yasuhiro¹⁰,Al-Batran Salah-Eddin¹¹,Passalacqua Rodolfo¹²,Ohtsu Atsushi¹³,Emig Michael¹⁴,Ferry David¹⁵,Chandrawansa Kumari¹⁵,Hsu Yanzhi¹⁵,Sashegyi Andreas¹⁶,Liepa Astra M.¹⁶,Wilke Hansjochen¹⁷

Affiliation:

1. Dana-Farber Cancer Institute, Boston, MA, USA.

2. Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.

3. Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

4. University Hospital Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.

5. Gangnam Severance Hospital, Seoul, Korea.

6. Korea University Guro Hospital, Seoul, Korea.

7. Oncology Research Group, Brown University, Providence, RI, USA.

8. Szent László Hospital, Budapest, Hungary.

9. Royal Marsden Hospital, London and Surrey, United Kingdom.

10. Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.

11. Institute of Clinical Research, Universitären Centrum für Tumorerkrankungen-University Cancer Center, Frankfurt, Germany.

12. Istituti Ospitalieri di Cremona, Cremona, Italy.

13. Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.

14. Lilly Deutschland GmbH, Bad Homburg, Germany.

15. Eli Lilly and Company, Bridgewater, NJ, USA.

16. Eli Lilly and Company, Indianapolis, IN, USA.

17. Departments of Oncology and Hematology with Integrated Palliative Care, Kliniken Essen-Mitte, Essen, Germany.

Funder

Eli Lilly and Company

Publisher

The Korean Gastric Cancer Association

Subject

Cancer Research,Gastroenterology,Oncology

Link

https://synapse.koreamed.org/pdf/10.5230/jgc.2017.17.e16

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancer;Cancer Medicine;2023-10

2. Prognostic significance of lactate dehydrogenase and its impact on the outcomes of gastric cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-09-01

3. Prognostic value of patient reported outcomes in advanced gastro‐oesophageal cancer: a systematic review;Internal Medicine Journal;2023-08-22

4. Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial;Gastric Cancer;2023-04-28

5. Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis;BMC Cancer;2023-02-10